ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,568Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 315

$601K Total Retail Price of All Prescriptions

Rank: 45 out of 315

860 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 860 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

7% of this provider’s 860 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 6,922 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 663 624 1 1
LISINOPRIL 435 419 2 3
LOSARTAN POTASSIUM 331 312 3 4
ATENOLOL 305 275 4 11
AMLODIPINE BESYLATE 253 241 5 2
HYDROCHLOROTHIAZIDE 212 205 6 16
METOPROLOL TARTRATE 171 164 7 18
ALLOPURINOL 170 158 8 14
WARFARIN SODIUM 164 154 9 20
GLIPIZIDE 163 149 10 30
METFORMIN HCL 158 140 11 7
ZOLPIDEM TARTRATE 154 138 12 29
ATORVASTATIN CALCIUM 150 141 13 5
OXYCODONE-ACETAMINOPHEN 139 110 S2 14 112
HYDROCODONE-ACETAMINOPHEN 129 106 S3 15 19
PROAIR HFA 128 115 16 52
INSULIN SYRINGE 101 98 17 79
FLUTICASONE PROPIONATE 100 87 18 53
QVAR 96 78 19 144
FUROSEMIDE 91 89 20 15
LEVOTHYROXINE SODIUM 89 81 21 6
CLOPIDOGREL 85 79 22 25
DONEPEZIL HCL 84 84 23 28
LEVOTHROID 79 77 24 61
DIGOXIN 69 68 25 45
NOVOLIN 70-30 66 63 26 175
GABAPENTIN 64 64 27 37
ADVAIR DISKUS 63 63 28 46
TERAZOSIN HCL 63 63 28 63
OXYCODONE HCL 62 34 S2 30 57
PREDNISONE 60 59 31 41
TRIAMCINOLONE ACETONIDE 58 55 32 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 52 33 50
PLAVIX 56 56 34 40
DILT-XR 52 52 35 215
TAMSULOSIN HCL 52 52 35 21
K-TAB 52 52 35 101
PRAVASTATIN SODIUM 51 51 38 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.